drugset / Trial / NCT02746848

Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing

NCT02746848

Phase 1/2 Completed 20 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

For severe ocular surface diseases, such as chemical and thermal injuries, Stevens-Johnson syndrome (SJS), Band Keratopathy, Corneal Dystrophies, Refractive (PRK-LASEK), corneal surgery and others, it is important that short time treatment with minimal side effect should be considered. This study is a prospective clinical trial to use Amniotic Membrane Extract Eye Drop (AMEED) as a natural substance for acceleration of corneal healing

Timeline

Start
2014-06
Primary completion
2015-05
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Amniotic Membrane Extract Unknown Other

Indications